Phase
Condition
Glaucoma
Treatment
Brillouin Microscopy
Beta Blocker
Prostaglandin Analogue -Containing IOP-Lowering Therapy
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 years or older
Diagnosis of primary open angle glaucoma (POAG) or no history of glaucoma (for controls)
Open angle on gonioscopy (Shaffer grade 3 or 4)
Best-corrected visual acuity of 20/25 or better
Refractive error between +3.00 and -5.00 diopters
No prior use of topical glaucoma medications
Diagnosis of:
High Tension Glaucoma (IOP ≥ 22 mmHg on 3 visits)
Normal Tension Glaucoma (IOP ≤ 21 mmHg on 3 visits)
OR age-matched control with normal optic nerve and visual fields
Exclusion
Exclusion Criteria:
Corneal abnormalities or conditions interfering with Brillouin or applanation tonometry
Retinal diseases affecting RNFL (e.g., macular traction)
History of ocular surgery or laser
Diagnosis of diabetes
History of uveitis
History of prolonged steroid use
Neurodegenerative or systemic diseases (e.g., multiple sclerosis, Alzheimer's, Parkinson's, schizophrenia)
Unreliable visual fields
Contraindications to beta blockers (e.g., bradycardia, severe pulmonary disease)
Moderate to severe glaucoma (per Hodapp-Anderson-Parrish criteria)
History of contact lens use
Low blood pressure
Study Design
Study Description
Connect with a study center
University of Maryland School of Medicine
Baltimore, Maryland 21201-1757
United StatesSite Not Available
University of Maryland School of Medicine
Baltimore 4347778, Maryland 4361885 21201-1757
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.